CIK 0001604821
- Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010894487
- Phone
- +1 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- 4 Planned sale Director sold 109 shares at $267.99 ($29,211)
- 4 Planned sale Director sold 479 shares at an average $257.93 ($123,549)
- 4 Planned sale EXECUTIVE CHAIRMAN sold 1,718 shares at $260.49 ($447,523)
- 4 Planned sale SEC. AND CHIEF LEGAL OFFICER sold 1,887 shares at an average $257.08 ($485,106)
- 4 Planned sale PRESIDENT, CLINICALDIAGNOSTICS sold 2,214 shares at an average $257.00 ($568,997)
- 4 Planned sale PRESIDENT, CHIEF BUS. OFFICER sold 1,713 shares at an average $257.00 ($440,243)
- 4 Planned sale CEO AND PRESIDENT sold 5,770 shares at an average $256.51 ($1,480,047)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 5,064 shares at an average $253.28 ($1,282,634)
- 4 Planned sale Director sold 1,500 shares at an average $273.88 ($410,825)
- 4 Planned sale Director sold 135 shares at $274.82 ($37,101)
- 4 Planned sale Director sold 3,150 shares at an average $265.68 ($836,898)
- 4 Planned sale EXECUTIVE CHAIRMAN sold 1,000 shares at $280.00 ($280,000)
- 4 Planned sale SEC. AND CHIEF LEGAL OFFICER sold 16,800 shares at an average $272.29 ($4,574,431)
- 4 Planned sale PRESIDENT, CLINICALDIAGNOSTICS sold 3,000 shares at an average $272.90 ($818,711)
- 4 Grant or award Director acquired 75 shares (grant or award)
- 4 Grant or award Director acquired 1,677 shares (grant or award)
- 4 Grant or award Director acquired 1,669 shares (grant or award)
- 4 Grant or award Director acquired 1,905 shares (grant or award)
- 4 Grant or award Director acquired 1,674 shares (grant or award)
- 4 Grant or award Director acquired 1,691 shares (grant or award)
Page 3 of 64 · 1,274 filings